NHAS

Novo Holdings A/S Portfolio holdings

AUM $1.29B
1-Year Est. Return 46.37%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+46.37%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.93B
AUM Growth
-$321M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
57
New
Increased
Reduced
Closed

Top Buys

1 +$153M
2 +$19.4M
3 +$5.75M
4
PHVS icon
Pharvaris
PHVS
+$5.27M
5
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
+$4.32M

Top Sells

1 +$61.5M
2 +$44.5M
3 +$36M
4
INZY
Inozyme Pharma
INZY
+$31.8M
5
PTGX icon
Protagonist Therapeutics
PTGX
+$26.9M

Sector Composition

1 Healthcare 57.28%
2 Financials 8.56%
3 Technology 7.59%
4 Consumer Discretionary 1.65%
5 Communication Services 1.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
51
-600,010
52
-31,769
53
-11,854
54
-508,922
55
-422,382
56
-1,867,706
57
-53,300